BURLINGTON, N.C.--(BUSINESS WIRE)--Labcorp (NYSE: LH), a leading global life sciences company, today announced the opening of a new diagnostics laboratory in South Bend, Indiana, allowing the company to enhance service levels and offerings to patients and physicians in South Bend and throughout the region.
The approximately 25,000-square-foot facility features expanded capabilities and new equipment for performing high-quality and efficient testing—creating more robust lab offerings for the community. The laboratory, which currently employs 100 individuals, will include STAT testing to expedite results for high-priority tests.
“This new lab offers increased capabilities for microbiology testing, allowing for a more flexible test menu that is tailored to fit the needs of our providers,” said Amy Rhine-Pallas, senior vice president of Labcorp’s North Central Division. “Ultimately, this leads to better patient diagnoses and outcomes. Our goal is to continue to invest in and provide the highest-quality service to patients and health care providers across the Midwest.”
Labcorp acquired the diagnostic clinical laboratory testing business of South Bend Medical Foundation in October 2019, considerably enhancing the scope of local services Labcorp offers to hospitals, physicians and patients across parts of Indiana, Michigan, Ohio and Illinois. The new laboratory further expands services to include northwestern Indiana and southern Michigan, and provides the communities in these areas with increased access and more efficient diagnostic testing solutions. In addition, the laboratory underscores Labcorp’s commitment to Indiana and builds on its strong operating presence in the state, which includes Labcorp Drug Development’s central laboratory and other facilities in Indianapolis. Labcorp currently has a number of open positions at the South Bend facility. To apply for one of these jobs, please visit: http://www.labcorp.com/careers.
Labcorp is a leading global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. Through our unparalleled diagnostics and drug development capabilities, we provide insights and accelerate innovations to improve health and improve lives. With over 70,000 employees, we serve clients in more than 100 countries. Labcorp (NYSE: LH) reported revenue of $14 billion in FY2020. Learn more about us at www.Labcorp.com or follow us on LinkedIn and Twitter @Labcorp.